Effect Gastric emptying slows by up to 30%, dramatically reducing hunger and blunting blood sugar spikes
Semaglutide was first FDA-approved for use as a type 2 diabetes medication
However, experts have started to take it more seriously in recent years, and research is underway to find out why it happens and how to treat it
According to a meta-analysis evaluating 453 trials and 21 antidiabetic treatments, oral semaglutide reduces all-cause mortality and cardiovascular death, with the lowest odds ratios (ORs) among the treatments evaluated (empagliflozin, liraglutide, extended-release exenatide, dapagliflozin, dulaglutide, lixisenatide, canagliflozin, pioglitazone, DPP-4 inhibitors, subcutaneous semaglutide, sulphonylureas) [56]
Healthcare professionals play a key role in educating patients on the importance of proper storage and providing guidance on how to store semaglutide correctly
Weekly subcutaneous self-injection